Periscope Capital Inc. Abb Vie Inc. Transaction History

Periscope Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $185,924 - $236,370	-1,351 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $55,431 - $68,775	-420 Reduced 23.72%	1,351 $219,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $190,258 - $240,732	1,771 New	1,771 $239,000
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $530,525 - $589,778	-5,967 Closed	0 $0
Q2 2018 Jul 25, 2018	BUY	$89.78 - $106.23 $535,717 - $633,874	5,967 New	5,967 $552,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Periscope Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Periscope Capital Inc. with notifications on news.